GT200200139A - Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales - Google Patents

Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales

Info

Publication number
GT200200139A
GT200200139A GT200200139A GT200200139A GT200200139A GT 200200139 A GT200200139 A GT 200200139A GT 200200139 A GT200200139 A GT 200200139A GT 200200139 A GT200200139 A GT 200200139A GT 200200139 A GT200200139 A GT 200200139A
Authority
GT
Guatemala
Prior art keywords
animals
methods
mycoplasma bovis
vaccine
bovis vaccine
Prior art date
Application number
GT200200139A
Other languages
English (en)
Inventor
Robin Lee Keich
David Ross Mcgavin
Robert John Yancey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200200139A publication Critical patent/GT200200139A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A VACUNAS DE MYCOPLASMA BOVIS QUE PUEDE SER UNA PREPARACION DE CELULAS TOTALES O PARCIALES INACTIVADAS O VIVAS MODFICADAS, UNA VACUNA DE SUBUNIDADES O UNA VACUNA DE ACIDO NUCLEICO O ADN QUE SON UTILES EN INFECCIONES CAUSADAS CON MYCOPLASMA BOVIS.
GT200200139A 2001-07-02 2002-07-02 Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales GT200200139A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30263801P 2001-07-02 2001-07-02

Publications (1)

Publication Number Publication Date
GT200200139A true GT200200139A (es) 2003-02-13

Family

ID=23168600

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200200139A GT200200139A (es) 2001-07-02 2002-07-02 Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales

Country Status (31)

Country Link
US (1) US20030147914A1 (es)
EP (1) EP1401488A1 (es)
JP (1) JP2004536106A (es)
KR (1) KR20040030783A (es)
CN (1) CN1522152A (es)
AP (1) AP2002002568A0 (es)
AR (1) AR036125A1 (es)
BG (1) BG108496A (es)
BR (1) BR0210798A (es)
CA (1) CA2452580A1 (es)
CZ (1) CZ20033465A3 (es)
EA (1) EA200301324A1 (es)
GT (1) GT200200139A (es)
HN (1) HN2002000162A (es)
HR (1) HRP20031078A2 (es)
HU (1) HUP0501188A2 (es)
IL (1) IL159516A0 (es)
IS (1) IS7078A (es)
MA (1) MA27048A1 (es)
MX (1) MXPA03011815A (es)
NO (1) NO20035767L (es)
OA (1) OA12640A (es)
PA (1) PA8549801A1 (es)
PE (1) PE20030239A1 (es)
PL (1) PL373891A1 (es)
SK (1) SK15802003A3 (es)
TN (1) TNSN03154A1 (es)
UY (1) UY27365A1 (es)
WO (1) WO2003004052A1 (es)
YU (1) YU102103A (es)
ZA (1) ZA200309747B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US7279166B2 (en) * 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
US7572455B2 (en) * 2004-05-19 2009-08-11 Boehringer Ingelheim Vetmedica Gmbh Vaccine comprising an attenuated pestivirus
UY29915A1 (es) * 2005-11-15 2007-06-29 Boehringer Ingelheim Vetmed Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina
EP2121721A4 (en) * 2006-09-07 2010-10-06 Boehringer Ingelheim Vetmed GENOTYPING BASED ON PCR
RS54981B1 (sr) 2006-09-11 2016-11-30 Zoetis P Llc Bakterini tretirani toplotom i vakcine tipa emulzije izrađene od ovakvih bakterina tretiranih toplotom
AR069087A1 (es) * 2007-10-29 2009-12-30 Boehringer Ingelheim Vetmed Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
AU2009265092B2 (en) * 2008-07-03 2015-09-03 Biotechnology Research And Development Corporation Cattle vaccines
AU2009309041B2 (en) * 2008-10-31 2016-02-04 Boehringer Ingelheim Animal Health USA Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
US8846054B2 (en) * 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
CA2764424C (en) 2009-06-04 2019-12-31 National Institute Of Advanced Industrial Science And Technology Vaccine for mycoplasma infection
CN102220263B (zh) * 2011-05-06 2012-10-03 华中农业大学 一种牛支原体致弱菌株及其应用
CN104968365B (zh) 2012-12-28 2018-04-03 勃林格殷格翰动物保健有限公司 支原体疫苗的制备方法
CN104857509A (zh) * 2015-06-02 2015-08-26 福清市默克兽医院 牛支原体肺炎组织灭活疫苗的制备方法、配方及使用方法
PL3334454T3 (pl) 2015-08-14 2023-01-30 Zoetis Services Llc Kompozycje mycoplasma bovis
CN105441368B (zh) * 2016-01-19 2019-01-01 福清市默克兽医院 一株牛支原体及其应用
CN106929452B (zh) * 2017-04-11 2020-06-12 河南省农业科学院畜牧兽医研究所 一株牛支原体及其应用
CN109022314B (zh) * 2018-08-06 2021-08-13 北京华夏兴洋生物科技有限公司 一株牛支原体及其在疫苗研制中的应用
CN110338138B (zh) * 2019-06-19 2021-04-06 山东省农业科学院奶牛研究中心 一种牛支原体感染豚鼠的动物模型构建方法及其应用
CN112301041B (zh) * 2020-10-09 2022-05-24 华中农业大学 牛支原体p21蛋白及其应用
CN113546162B (zh) * 2021-05-31 2023-07-18 江苏省农业科学院 一种支原体疫苗及其制备方法
CN113604492B (zh) * 2021-09-10 2023-07-07 苏州世诺生物技术有限公司 融合基因、融合蛋白及制备方法和牛支原体亚单位疫苗

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
WO2001034189A2 (en) * 1999-11-08 2001-05-17 Biomune Vaccines for mycoplasma bovis and methods of use
DE29921392U1 (de) * 1999-12-06 2000-03-16 Felgentraeger & Co Oeko Chem U Mykoplasma-bovis-Kombinations-Vakzine für Rinder
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin

Also Published As

Publication number Publication date
AR036125A1 (es) 2004-08-11
MXPA03011815A (es) 2004-04-02
UY27365A1 (es) 2003-04-30
WO2003004052A1 (en) 2003-01-16
BR0210798A (pt) 2006-05-23
HUP0501188A2 (en) 2006-05-29
CN1522152A (zh) 2004-08-18
HN2002000162A (es) 2002-09-17
YU102103A (sh) 2006-05-25
PE20030239A1 (es) 2003-03-21
ZA200309747B (en) 2005-05-27
PL373891A1 (en) 2005-09-19
AP2002002568A0 (en) 2002-06-30
PA8549801A1 (es) 2003-09-17
KR20040030783A (ko) 2004-04-09
JP2004536106A (ja) 2004-12-02
IL159516A0 (en) 2004-06-01
US20030147914A1 (en) 2003-08-07
BG108496A (en) 2005-02-28
NO20035767L (no) 2004-01-30
OA12640A (en) 2006-06-15
TNSN03154A1 (fr) 2005-12-23
SK15802003A3 (sk) 2005-01-03
HRP20031078A2 (en) 2005-08-31
EA200301324A1 (ru) 2004-12-30
IS7078A (is) 2003-12-15
MA27048A1 (fr) 2004-12-20
EP1401488A1 (en) 2004-03-31
CA2452580A1 (en) 2003-01-16
CZ20033465A3 (cs) 2004-12-15

Similar Documents

Publication Publication Date Title
GT200200139A (es) Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales
AR034677A1 (es) Vacuna de mycoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado
PA8549701A1 (es) Vacunacion en dosis unica con mycoplasma hyopneumoniae
WO2003059381A3 (en) Immunogenic preparations and vaccines on the basis of mrna
DK1487485T3 (da) Imidazoquinolinadjuvanser til DNA-vacciner
NO20023829D0 (no) Proteosom influensavaksine
CO2022012272A2 (es) Vacunas contra el coronavirus y métodos de uso
DE602004028029D1 (en) Rwendung
WO2009077577A3 (en) Vaccine antigens from piscirickettsia salmonis
WO2002081621A3 (fr) Vaccin contre le virus de la fievre du nil
ATE526034T1 (de) Verbesserte inaktivierte fcv-vakzinen
NO20062469L (no) Streptococcus phocae vaksine
CY1107538T1 (el) Εμβολιο μυκοπλασματος αδρανοποιημενο με σαπωνινη
UY26763A1 (es) Inmunización del ganado lacteo con proteína gapc quimérica contra infección por estreptococo.
DE602004024968D1 (de) Francisella-stamm für lebenden impfstoff
DE602005011041D1 (de) Wachstumshormon-freisetzendes hormon verstärkt die vakzin-induzierte immunantwort
CR11384A (es) Proteina m de estreptococo, fragmentos inmunogenicos, acidos nucleicos y metodos de uso
DE60239753D1 (de) Impfstoff gegen infektiöses lachsanämievirus
AR109627A1 (es) Polipéptidos insecticidas que tienen un espectro de actividad mejorado y usos de estos
ATE515270T1 (de) Phep, eine aminosäurepermease von staphylococcus aureus
AR042237A1 (es) Obtencion de estructuras cocleares, composiciones vacunales, adyuvantes y sus intermediarios
AR127816A1 (es) Formulaciones de vacunas contra el coronavirus
Anderson et al. A SARS-CoV-2 vaccine designed for manufacturability results in unexpected potency and non-waning humoral response.
BR0110791A (pt) Composição, métodos para induzir uma resposta imune em um indivìduo contra um imunogene, para modular o sistema imune de um indivìduo e para imunizar um indivìduo contra um patógeno, vacina recombinante, e patógeno atenuado vivo
AR121151A1 (es) Formulaciones para vacuna contra coronavirus